Why rich countries are hoarding smallpox vaccines
Danish pharma company has doubled its revenue projections as orders flood in

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
Wealthier countries are responding to the monkeypox outbreak by ordering more smallpox vaccines than they require, risking a reprise of the vaccine inequality seen during the Covid-19 pandemic.
A total of 366 confirmed monkeypox cases have been identified in the UK, and a further 275 in Spain, 209 in Portugal and 48 in the US. Rich countries are responding by “ordering more vaccines than they’ll arguably need”, said Quartz.
The vaccine attracting such interest is actually for smallpox but is estimated to provide 85% protection against monkeypox.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The US has ordered half a million doses, on top of the 1.5 million it already had stockpiled. The vaccine’s Danish maker, Bavarian Nordic, has received so many orders that it has more than doubled its revenue projections.
Last month, Bavarian Nordic said an undisclosed country had ordered sufficient doses to cover its potentially at-risk population in the short and medium term.
The company said it was also “currently in dialogue” with several other governments concerning supply of the vaccine to mitigate the current outbreak and to “explore opportunities for longer term collaboration to build stockpiles for future preparedness”.
Despite the presence of monkeypox in Africa for decades, there has been little investment into preventing and treating cases. Therefore, said Quartz, the “best option” is to use vaccines and therapeutics developed in case of a smallpox terror attack.
Last month, Dr Luigi Ferrucci, scientific director of the National Institute on Aging, told The New York Times that older adults are partially protected by distant smallpox vaccinations.
“The bottom line is that even those that were vaccinated many decades before maintain a very, very high level of antibodies and the ability to neutralise the virus,” he said. “Even if they were vaccinated 50 years ago, that protection should still be there.”
News of smallpox jabs being hoarded by wealthier countries has reignited concern about vaccine inequality. During the Covid pandemic, the World Health Organization said that the “global failure to share vaccines equitably” was “taking its toll on some of the world’s poorest and most vulnerable people” and leading to new variants of concern that meant that the risks of infection “increased in all countries for people who are not yet protected by vaccination”.
The monkeypox virus was discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research, says the UK government website’s infectious diseases portal.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
You can now get a new Covid booster shot. Should you?
Unless you are old or otherwise at high risk, it isn't a 'slam dunk'
By Peter Weber Published
-
New Covid variant BA.2.86: does the UK booster programme go far enough?
Talking Point Some MPs and experts say criteria for jabs is ‘too narrow’ ahead of ‘rocky ride’ this winter
By Chas Newkey-Burden Published
-
Covid testing to be ramped up for winter
Speed Read Scientists fear UK could be ‘flying blind’ on infection rates due to lack of monitoring programmes
By Harriet Marsden Published
-
Is it time to mask up again?
Today's Big Question A rise in Covid-19 cases brings back the possibility of mask mandates
By Joel Mathis Published
-
The NHS plan for virtual wards to beat winter crisis
feature Patients with respiratory infections to be given wearable devices that allow doctors to monitor them at home
By The Week Staff Published
-
Understanding the new Covid-19 variant, Eris
Speed Read The formally named EG.5 is making the rounds, but we don't have to worry just yet
By Devika Rao Published
-
The new Covid variant Eris behind a rise in cases this summer
feature Concerns over ’flying blind’ as routine testing is no longer freely available and less data is being collected
By Felicity Capon Published
-
The new push to solve long Covid
Speed Read Patients say researchers have been too slow to address the condition
By Joel Mathis Published